Evidence map›Paper›PMID 38836150›Full record

ReviewCureus2024

Gender Disparities in Cardiovascular Disease and Their Management: A Review.

Dhruva Betai, Aamina S Ahmed, Prerna Saxena, Hurria Rashid, Happy Patel, Atika Shahzadi, Adetola G Mowo-Wale, Zahra Nazir

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Observational
  9. Review
  10. Alzheimer's Disease Risk Factor APOE4 Exerts Dimorphic Effects on Female Bone.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Emerging roles of spexin in cardiovascular homeostasis.Frontiers in cardiovascular medicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dhruva BetaiGeneral Practice, Pandit Deendayal Upadhyay Medical College, Rajkot, IND.
Aamina S AhmedInternal Medicine, St. George's University School of Medicine, New York, USA.
Prerna SaxenaMedicine and Surgery, K. S. Hegde Medical Academy, Mangalore, IND.
Hurria RashidBasic Sciences, Fatima Jinnah Medical University, Lahore, PAK.
Happy PatelInternal Medicine, Angeles University Foundation, Angeles City, PHL.
Atika ShahzadiMedicine, Aziz Bhatti Shaheed Teaching Hospital, Gujrat, PAK.
Adetola G Mowo-WaleInternal Medicine, Obafemi Awolowo College of Health Sciences, Sagamu, NGA.
Zahra NazirInternal Medicine, Combined Military Hospital Quetta, Quetta, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Worldwide, cardiovascular diseases (CVDs) are still the primary cause of death, and there are notable differences between sexes when it comes to symptoms/course and treatment. Due to evolving healthcare technologies, significant progress has been made in understanding CVDs. Hence, it is evident that gender disparities exist in the clinical presentation, prevalence, management, outcomes, and risk factors, including biological, behavioral, and sociocultural factors. This narrative review is designed to provide a generalized idea of gender disparities in CVDs. It aims to provide insights to prove the role of hormonal influences, genetic predispositions, and the difference in physiological outcomes owing to different genders. This review explores subtle distinctions in CVD across genders, including changes in structure, biology, and hormones that affect how illness presents and progresses. Lifestyle variables also influence sociocultural factors and gender disparities in risk profiles. Traditional risk factors, diabetes mellitus (DM), cholesterol levels, and smoking may have different weights and relevance in men and women. Moreover, age and other conventional risk variables have distinct effects on gender. Treatment efficacy may be impacted by the expression of gender-specific factors, emphasizing the necessity for customized strategies. Development of CVDs can be delayed or prevented, and its consequences can be lessened with the early identification and effective management of gender-specific factors. More investigation is necessary to clarify complex interactions between structural, biochemical, and hormonal aspects across genders in order to maximize treatment results and reduce the burden of CVDs.

Indexed as

add-on pharmacotherapycardiology cornerecg abnormalitiesgender rolehealth aging

Identifiers

PMID38836150
PMCPMC11148660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.